Aytu BioScience, Inc. (OTCQB: AYTU), a specialty healthcare company focused on developing treatments for urological and related conditions, announced today that the company is now trading under the ...
LOS ANGELES--(BUSINESS WIRE)-- ChromaDex Corp. (CDXC) (NASDAQ:CDXC), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announced that ...
HOUSTON, Texas, Aug. 21, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire-- Cannabis Bioscience International Holdings (the “Company”) a diversified medical and educational company with a particular focus on ...
As part of this transition, the Company will deploy a follow-up announcement with additional updates regarding the name change, rebrand, and future initiatives. No action is required by existing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results